Amy Stulick

Staff Reporter (Health Care, Law)

Email: astulick@sfvbj.com
Phone: 818-316-3121 Extension: 112

Recent Stories

IT Service Seeks Impact on Clients

Stephen Yeoh left corporate job to work with small businesses.

Stephen Yeoh decided to start IT company Un1teee in 2009 after working for a variety of large companies including Amgen Inc. in Thousand Oaks.

Two Brewers in Glendale

Kirk Nishikawa had to rewrite his business plan during COVID.

Kirk Nishikawa owns Brewyard Beer Co. with partner Sherwin Antonio.

Conejo Valley Firm Adds Shareholders

Both attorneys are active in Asian bar associations.

Sharlene Lee and Reema Kapoor have been elected as shareholders of Nevers Palazzo Packard Wildermuth & Wynner Law Firm, the company announced in April.

COVID’s Long Tail

Employers may see ‘enormous costs’ in the workplace for years after pandemic ends.

Employers may see ‘enormous costs’ in the workplace for years after pandemic ends.

CSUN Legal Program’s Success in Six

Students accepted to study for bachelors and law degrees.

California State University – Northridge and Southwestern Law School are finally seeing the fruits of their partnership, with students graduating from the jointly formed accelerated legal program.

All-Stock Merger for Bank of Santa Clarita

Combination will create entity with $2 billion in assets.

Bank of Santa Clarita acquired in all-stock deal by San Diego financial institution.

Post-Pandemic Hospitals

From the waiting room to virtual visits, the pandemic has altered the health care industry’s future trajectory.

How the pandemic has altered the health care industry’s future trajectory.

Tease photo

Will Scorpion Lab Yield Venom Drugs?

Burbank company aims to produce 1 million doses monthly.

Medolife Rx Inc. breaks ground on facility to raise scorpions, whose peptides are used to make therapeutics.

Doctor Charged With Medicare Fraud

A Porter Ranch physician was indicted Thursday on charges related to an alleged $6 million Medicare fraud scheme, according to the Justice Department.

Amgen’s Otezla May Be Approved for Broader Use

Amgen Inc. on Wednesday said its psoriasis drug Otezla was approved for review by the Food and Drug Administration to be used on a wider patient population.

More stories >>